AI Adaptation Research Report — HNGE (Hinge Health, Inc.) · WhiteSwan constituent
EventTrader research desk · generated 2026-11-22 20:51 UTC · report ai-adapt-hnge-20261122 · narrative: built from the evidence pack by the platform
| Company | HNGE — Hinge Health, Inc. · SIC 7374 Services-Computer Processing & Data Preparation |
| Book | AMF-WHITESWAN (long) — WhiteSwan |
| Composition algorithm | Swan Composite v1.1.0 — 50% AI Adaptation Score + 25% AI Story Score + 25% market verdict, conviction-weighted |
| Anchor filing | 10-Q filed 2026-11-09 (period 2026-09-30) |
| Adoption level | 3 — integrated · model-confirmed |
| AI Adaptation Score | 56.7 / 100 · run 2026-11-22 · sector software percentile 91.9 |
| Price | 108.1 USD |
| Place in the book | rank 10 of 10 · composite 65.8 · story 50.0 · market verdict 100.0 · weight 6.7% |
1. Verdict
- HNGE (Hinge Health, Inc.) is a WhiteSwan constituent: its own filings document AI inside the product or operations with investment behind it, and its AI Adaptation Score ranks at the top of the software companies (SIC 7370–7379) on the 2026-11-22 run [S5].
- The score rests on the company's 10-Q filed 2026-11-09, read in full by the platform's scorer [S1].
- Adoption level 3 — integrated on the 0–4 rubric, confirmed by a model read with credibility 5.0/10 [S1].
- AI Adaptation Score 56.7 / 100, percentile 98.3 of 6561 scored filers and 91.9 within its sector (software, 590 filers) [S5].
- What would move it: a next report that withdraws the deployments, investment or outcomes it now states [S1].
2. The company
Hinge Health, Inc. files with the SEC under CIK 1673743, SIC 7374 (Services-Computer Processing & Data Preparation), listed on NYSE [S4]. The filing the score reads is the 10-Q filed 2026-11-09 for the period ended 2026-09-30, effective for the books from 2026-11-10 [S2].
3. What the filing says about AI
The scorer found 45 AI-related sentences in the 10-Q: 9 in the substantive sections (business, management's discussion) and 36 in the risk factors [S1]. Signals counted in the substantive text: proprietary-model language 5, deployments 4, measured outcomes 0, investment 0, third-party vendor tools 0, exploratory language 0 [S1].
Verbatim from the filing:
"Over the last four years, we launched launched Enso to deliver a non-addictive, non-invasive alternative for pain relief; developed HingeConnect for real-time targeted care support and external provider coordination; and integrated TrueMotion, our proprietary AI-powered motion tracking technology, to replace wearable sensors for our members." — Item 2. Management's Discussion and Analysis [S1] "These innovations include TrueMotion, our proprietary AI-powered motion tracking technology, Enso, our FDA-cleared, wearable device for lasting pain relief, and HingeConnect, our proprietary AI-driven database for real-time care interventions and external provider coordination." — Item 2. Management's Discussion and Analysis [S1] "Members receive personalized and automated care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, registered dietitians, and board-certified health coaches." — Item 2. Management's Discussion and Analysis [S1] "We enable positive member outcomes and proven cost reductions by pairing an AI-powered care model and wearable devices have continually driven innovations in automating care since 2014." — Item 2. Management's Discussion and Analysis [S1] "The acquisition is intended to combine Cylinder's clinical expertise and existing market footprint with Hinge Health’s AI-powered care model and technology platform to deliver support in a single app with an integrated Gastrointestinal Care Program, expected to launch in 2027." — Item 2. Management's Discussion and Analysis [S1] "Our software-led, AI-powered delivery model not only aims to provide a better experience for our members and a less expensive alternative for our clients, but also allows us to innovate and continuously improve our platform." — Item 2. Management's Discussion and Analysis [S1] "Our AI-powered motion tracking technology, TrueMotion, allows us to deliver highly scalable care remotely and reduce the human hours associated with traditional physical therapy." — Item 2. Management's Discussion and Analysis [S1] "Our software-led, AI-powered delivery model aims to provide a better experience for our members and a less expensive alternative for our clients." — Item 2. Management's Discussion and Analysis [S1] "We use AI and generative AI, machine learning, and automated decision-making technologies, including proprietary AI and machine learning algorithms and models (collectively, “AI Technologies”) throughout our business, and are making significant investments in this area." — Item 1A. Risk Factors [S1] "Once fully implemented, the EU AI Act will include requirements around transparency, conformity assessments and monitoring, risk assessments, human oversight, security, accuracy, general purpose AI, and foundation models, and provides for fines of up to the greater of €35 million or 7% of worldwide annual turnover for violations." — Item 1A. Risk Factors [S1]
4. The AI Adaptation Score
The AI Adaptation Score weighs the adoption level (0–4) at 45%, building with AI from the ground up (greenfield) at 20%, the credibility of the claims at 15%, the trajectory against the previous filing at 12% and the investment signal at 8%, with trajectory and investment measured against the company's own sector; the greenfield reward counts only from level 3 upward [S5]. HNGE's score of 56.7 decomposes into level 33.8, greenfield 6.0, credibility 7.5, trajectory 5.9 and investment 3.5 points [S5]. Its cluster label for the run is builder with a margin of 23.5 points from the sector's other cluster [S5].
The model read of the filing returned level 3 (integrated) with confidence 0.78 and sub-scores product 8.0, operations 8.0, investment 5.0, data moat 6.0, credibility 5.0, greenfield 3.0 (each 0–10) [S1]. Its summary: "Hinge Health embeds proprietary AI (TrueMotion, HingeConnect) in its core care-delivery model, reducing clinician hours and driving claimed cost reductions, with significant ongoing investment. Strong integration, but specific dollar figures and quantified outcomes are absent. AI retrofitted onto a 2014 care business, not AI-native. Stays at level 3." [S1].
"integrated TrueMotion, our proprietary AI-powered motion tracking technology, to replace wearable sensors for our members." — Item 2. Management's Discussion and Analysis [S1] "Our AI-powered motion tracking technology, TrueMotion, allows us to deliver highly scalable care remotely and reduce the human hours associated with traditional physical therapy." — Item 2. Management's Discussion and Analysis [S1] "HingeConnect, our proprietary AI-driven database for real-time care interventions and external provider coordination." — Item 2. Management's Discussion and Analysis [S1] "we use AI Technologies to support our care team and to assist with developing personalized exercise therapy plans, providing real-time feedback on an exercise form, identifying high-risk members for targeted interventions" — Item 1A. Risk Factors [S1]
5. Trajectory
The previous periodic report, the 10-Q filed 2026-08-06, scored level 3 (integrated) with 45 AI sentences [S3]. The level is unchanged between the two reports [S1].
6. Recent developments
No wire headline tagged HNGE in the last 45 days reached the platform's headline store [S5].
7. What would change the verdict
HNGE leaves the long book if a later report drops the deployments, investment or outcomes it now states, if the model read judges the claims uncredible, or if higher-scoring filers displace it on a later run [S5]. The book is recomposed on every scoring run from the ten highest scores that pass the liquidity screen [S5].
8. Risks and caveats
The score reads what the company discloses, not what it does: a company can adopt AI without describing it in a periodic report, and can describe it without adopting it [S5]. Risk-factor language is counted separately from substantive text and never credited as adoption; boilerplate that resembles generic risk disclosure is excluded [S5]. Only the sections the scorer parses are read (business, risk factors, management's discussion for a 10-K or 10-Q; the earnings release of an 8-K is scored but never anchors a level) [S5].
9. Watch list
- The next periodic report of HNGE (expected around 2027-02-07) and its AI sentences [S4].
- The model read of the current filing (done) [S5].
- The next scoring run's AI Adaptation Score and the book's recomposition [S5].
Place in the book
- Rank 10 of 10 in AMF-WHITESWAN (Swan Composite v1.1.0, scoring run 2026-11-22): the book holds the highest composites [S5].
- Composite: 0.50 × 56.7 (AAS) + 0.25 × 50.0 (story) + 0.25 × 100.0 (market) = 65.8 [S5].
- Market verdict 100.0: over the last 90 days HNGE rose more and fell less than the software universe's median daily return (down-capture 0.52, up-capture 3.18, L = 2.66; 36 down / 18 up days) — the Failure-To-Adapt fund's selection signal, 50 = moves with the software universe's median daily return [S5].
- AI Story Score 50.0: no AI story or a neutral one in the AI stories written about the company [S5].
- Weight: rank factor 1.00 (rank 10 of 10) × story factor 1.00 × market factor 1.50, normalised across the book and clamped to 5–20% → 6.7% [S5].
Sources
- S1 — HNGE 10-Q filed 2026-11-09 — SEC primary document (the anchor filing the score reads) — https://www.sec.gov/Archives/edgar/data/1673743/000162828026072251/hnge-20260930.htm
- S2 — EDGAR filing index for accession 0001628280-26-072251 — https://www.sec.gov/Archives/edgar/data/1673743/000162828026072251/
- S3 — HNGE 10-Q filed 2026-08-06 — the previous periodic report (trajectory) — https://www.sec.gov/Archives/edgar/data/1673743/000162828026054327/
- S4 — SEC EDGAR company submissions — Hinge Health, Inc. (CIK 1673743) — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1673743
- S5 — EventTrader AI Adaptation Score, scoring run 2026-11-22 — the AMF-WHITESWAN fund page (method, composition) — https://cymetica.com/fund-performance/AMF-WHITESWAN
- S6 — EventTrader real-price feed — HNGE quote — https://cymetica.com/api/v1/prices/HNGE
Method and disclaimer
The AI Adaptation Score reads each company's own periodic SEC reports (10-K, 10-Q, 20-F, 40-F): deterministic features (AI sentences by section, proprietary-model, deployment, outcome, investment and vendor language, boilerplate and negation excluded) set an adoption level on a 0–4 rubric; a model read of the filing's AI sentences confirms the level and scores credibility and greenfield (the business built with AI from the ground up rather than retrofitted); the score combines level, greenfield, credibility, trajectory against the previous report and investment, measured against the company's sector, with greenfield carrying the highest reward. The books are composed by Swan Composite v1.1.0: each company's composite is 50% AI Adaptation Score + 25% AI Story Score + 25% market verdict — the AI Story Score is the sentiment of the AI stories written about it, the belief network of companies named in the same stories and the price reaction to those stories (no story scores neutral); the market verdict is the Failure-To-Adapt fund's selection signal, the signed down/up capture ratio of the stock against the software universe's median return over 90 days (a stock that falls more and rises less than its peers scores below 50). AMF-BLACKSWAN holds the ten lowest composites that pass the liquidity screen and the new-listing gate and AMF-WHITESWAN the ten highest, weighted by conviction (rank, story agreement and market agreement, each leg 5–20%), recomposed on every scoring run. Every quote in this report is the filing's text verbatim; every factual sentence names its source; a source the platform could not reach is reported as missing, never filled in.
This report is information, not investment advice. Figures come from the cited sources as of their dates. Nothing here is a recommendation to buy, sell or hold any asset.